Inbox Insider: Pharmaceutical e-mail gains reputation among consumers

Share this article:

Pharmaceutical e-mail has come a long way. While the sector has experienced challenges in the past with spammers sending e-mails offering deals on pharmaceuticals such as Viagra, it seems that legitimate pharma marketers are beginning to take back their name.

Receiving permission-based e-mail from a pharmaceutical company can be a positive experience, according to a new survey by Epsilon. Among respondents, 42% said the permission-based e-mail they receive from pharmaceutical companies has a direct impact on offline activities, such as taking medication as instructed by a doctor and filling prescriptions.

In addition, 44% of the respondents said they're more likely to stay on a drug from a pharmaceutical company that sends them permission-based e-mail. This is a long way from the bad reputation that the pharma industry has faced in e-mail.

And, e-mail from a pharma company that you have opted into receive makes sense. E-mail has the benefits of connecting with consumers in such a personal way, and health care professionals and pharma companies can have a very intimate relationship with a consumer's health. So it is no surprise that the industry is looking to be able to speak to patients directly through e-mail.

It helps build the relationship. The study found that 60% of respondents have a more favorable opinion of pharmaceutical companies that send them permission-based e-mail, and 53% said they're more loyal to pharmaceutical companies that send them permission-based e-mail.

It seems like there could be a new way to look at pharma e-mails.

Share this article:
close

Next Article in Email Marketing

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

More in Email Marketing

Forrester: Keep Your Eye on the Email

Forrester: Keep Your Eye on the Email

Merging email with other channels is all well and good, but a Forrester Wave analysis holds that the email channel itself could stand improvement.

Email Opens Have Increased While Clicks Remain Static

Email Opens Have Increased While Clicks Remain Static

Open rates rose to 32.9% in Q1 2014, but clicks haven't changed for the past couple of years, a study says. But why?

Is Reliance on Email Stifling Lead Nurturing?

Is Reliance on Email Stifling Lead Nurturing?

Pressure to drive revenue has some B2B marketers looking to take a more multichannel approach to lead nurturing.